In this interview, Jinling Chen, head of WuXi STA’s drug product business, and Jamie Andrews, site head of WuXi STA’s Couvet facility, explain the company’s strategy and the goals of the European expansion.
Actylis, leading global manufacturer and sourcing expert of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, made its debut in September 2022. The new CDMO was created from US-based fine and specialty chemicals distributor Aceto. Gilles Cottier, CEO of Actylis, has played a tremendous role in Aceto’s transformation into the new Actylis brand. Ralf Kempf and Michael Reubold asked Cottier about the reasons for creating the new brand identity, the challenges of combining so many companies, and Actylis' strategy going forward.
Historically, China’s chemical industry has mainly been located in coastal provinces, with Shandong as the biggest and Jiangsu as the second biggest province by chemical sales, while the coastal regions of Hebei, Tianjin, Zhejiang, Liaoning and Guangdong are also among the top ten producers of chemicals.
2021 was historic for chemical M&As, it was a record-breaking year in terms of total value of deals. Therefore, it was expected that 2022 would only build upon this. However, the combination of high interest rates, supply chain bottlenecks and geopolitical instability saw both the number and value of deals take a significant hit throughout 2022.
Companies in the materials industry – including chemical companies – are seeing a revolution that is likely to drive a new wave of growth. To succeed, however, they will need to rethink their value chains, expand manufacturing in the region, and take advantage of digitally powered approaches to innovation.
In 2021, the new patent law came into force in China. It represents a significant strengthening of protection against patent infringements.
Every chemical company has safety rules, analysis tools, dashboards and a keen awareness of safety processes.
The 2022 edition of the IMD World Competitiveness Yearbook, compiled by the International Institute for Management Development (IMD), is published at a moment of tremendous turmoil.
The current crisis, exacerbated by the economic downturn and war in Ukraine, can be an opportunity to reduce dependence on fossil feedstocks and explore sustainable alternatives.
The European Commission proposed last month an emergency intervention in Europe’s energy markets to address recent dramatic price rises as the EU faces the effects of a severe mismatch between energy demand and supply. What is in the proposal?
Every year, the chemical industry sees hundreds of mergers and acquisitions (M&A). Traditional M&A drivers, such as consolidation and portfolio extension, are still important. But many transactions also show that the nature of M&A is evolving, as chemical companies look for ways to contend with ongoing volatility and move to a more sustainable future.
The increasing complexity in drug development and the highly competitive industry landscape are creating a dramatic shift in how pharmaceutical and biotech companies plan for and execute drug development and production.
Many chemical executives say their companies have made significant progress in their digitalization efforts in the last two years – and they are even more excited about it now.
Many chemical executives say their companies have made significant progress in their digitalization efforts in the last two years – and they are even more excited about it now.
The chemicals industry is one of the world’s largest industrial sectors, worth €3,471 billion in 2020. It includes producers of industrial chemicals, polymers, pesticides, food and feed additives, and cosmetics, and is growing rapidly. By some estimates it will reach almost $22,000 billion by 2060.
Chemical parks are locations of intensive value creation. They are a driver for sustainable development with a high economic, ecological and social impact.
Japan continues to be one of the largest pharmaceutical markets in the world, making up approximately 7% of the global share. Historically, Japan has been viewed as insular compared to other developed markets such as Europe or the US, with foreign companies reporting high barriers to entry.
The primary goal for any manufacturing or process organization is to produce a profit and return on net asset (RONA) to shareholders and other stakeholders. Safety and environmental performance are secondary goals – not secondary in importance, but no manufacturing plant was ever built with the sole and explicit purpose of being safe and environmentally responsible.
Management pays a lot of attention to new ideas and cutting-edge technologies, but most of their resources are consumed by mature legacy technologies that are often not actively and rigorously managed. A visual matrix can help teams understand which technologies offer the greatest long-term potential for businesses.
One of China’s key objectives of the current 14th Five-Year Plan is to reduce the dependency on imports. At least partly, this is a reaction to rising political tensions with the USA.
Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of the major investments by the larger CMDOs/CMOs are outlined in this article.
The EU Green Deal sets a high bar for reducing greenhouse gas (GHG) emissions, and its impact will be felt across industries. But the chemical sector’s unique nature means that it will be more deeply affected than other industries – and more deeply involved in making net zero a reality, as well.
For its annual report "Value Creation in Chemicals 2021 – Ten Years of Steady Growth – and a Few Superstars," the strategy consultancy Boston Consulting Group examined the performance of leading international chemical companies from 2011 to 2020. The long-term perspective shows that the industry has mastered serious market downturns with astonishing confidence.
In March 2022, Mercator by Citco published a report that provides direct insights into the practice and dynamics of Global Entity Portfolio Management (GEPM) within the pharmaceuticals sector – based on real-life data – when these businesses have been at the epicenter of one of the most significant global disrupters in modern times.
Investment in UK biotech and life science companies scored a lifetime high in 2021, according to new data from the BioIndustry Association (BIA) and Clarivate.
Innovation protection with the EU's unitary patent will be more uniform and cost-effective, but also harbors risks.
In his interview with CHEManager, Jeff Zhu, chairman of the Chinese Association of International Chemical Manufacturers (AICM), talks about the industry’s role in helping achieve China’s carbon-neutrality goal.
Storage conditions play a vital role in the entire supply chain of pharmaceutical products and must comply with strict regulations. From manufacturers to patients, storage conditions are essential for the quality, safety, and efficacy of medications.
In the past 20 years, the chemical industry in China has grown rapidly and today accounts for close to 40% of worldwide chemical-industry revenue. Understanding environment-related regulatory and policy shifts now in full swing in China is critical to ensuring compliance and reducing business interruption risks for chemical companies either operating in or sourcing from China.
The positive impacts of Predictive Maintenance are broad and should be considered holistically. No one ever said that nurturing a perfect rose garden was simple, but the results can be dramatic.
The second part of the 2021 CPhI Annual Report looks ahead to predict the pharma manufacturing, therapeutic and technology environment in 2030.
Leading global chemical companies and the World Economic Forum (WEF) have announced that they are entering an agreement to formalize the Low-Carbon Emitting Technologies (LCET) initiative into a stand-alone entity by the end of 2023, to share early-stage risks and co-invest in developing and upscaling low-carbon emitting technologies.
If you follow the daily news on climate protection and the promotion of hydrogen technologies, you sometimes get a sense of déjà vu: Didn't this already exist 20 years ago? What was implemented at that time? What sustainable hydrogen-based technologies can we expect today?
Successfully managing the drug substance manufacturing of Antibody-Drug Conjugates (ADCs) requires a sophisticated understanding of the technological development process and access to a range of large- and small-molecule manufacturing assets.
The Processes4Planet (P4Planet) partnership’s goal is to transform the European process industries to make them circular and achieve overall climate neutrality at EU level by 2050, while enhancing their global competitiveness.
